Actively Recruiting
An Effectiveness Evaluation for Pathway to Healthy Aging (Path-HA) Care on Health Status of Older Adults
Led by The University of Hong Kong · Updated on 2025-12-16
1000
Participants Needed
1
Research Sites
39 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the effects of the Pathway to Healthy Aging (Path-HA) Program on improving the health-related quality of life and functional abilities of community-dwelling older adults at risk of accelerated aging. This assessor-blind, randomized controlled trial focuses on six health areas including physical movement, vitality, psychological and cognitive functions, social connections, and overall health quality. The study will recruit 1000 participants and assess outcomes at the start, after the 14-week intervention, and again 6 months later to explore lasting benefits, including personal experiences through interviews. Participants will be randomly assigned to one of two groups: the intervention group receives a 14-week Path-HA care program, and the control group receives no care intervention. The Path-HA program is based on the WHO ICOPE model and includes two home visits for personalized care planning followed by a 12-week healthy aging empowerment phase. This empowerment phase involves interactive health education, health message broadcasts, and case conferences for goal monitoring and counseling. Participants will be involved in assessments measuring health-related quality of life, hand grip strength, balance, mobility, sarcopenia risk, nutrition, sleep quality, mood, cognitive functions, memory, loneliness, and social connectedness at baseline, after the intervention, and six months later. Researchers will monitor changes over time and gather in-depth feedback on participants' experience with the program. The trial is expected to run until March 2026.
CONDITIONS
Brief Title
An Effectiveness Evaluation for Pathway to Healthy Aging (Path-HA) Care on Health Status of Older Adults
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 60 or above
- Have at least two risk factors for accelerated aging, such as reduced physical function, malnutrition, depressed mood, loneliness, poor health perception, or geriatric symptoms like insomnia or pain
- Living in the community (not institutionalized)
- Able to communicate and participate in health education activities
You will not qualify if you...
- Having no or only one risk factor for accelerated aging
- Having communication problems that prevent engagement with the research team
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 14 weeks
Participants receive a 14-week care program comprising two phases: a 2-week ICOPE-based personalized care planning with two home visits, followed by a 12-week healthy aging empowerment program including interactive health education, health message broadcasts, and case conferences for goal monitoring and health counseling.
2 home visits during care planning and ongoing activities during 12-week empowerment phase
Duration - 6 months
Participants are evaluated for long-term benefits 6 months after completing the care program through outcome assessments and interviews about their experience and perceived benefits.
1 follow-up visit at 6 months post-intervention
Trial Site Locations
Total: 1 location
1
The University of Hong Kong
Hong Kong, Hong Kong
Actively Recruiting
Research Team
D
Doris Sau Fung YU, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here